|
🐜
|
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities
24 auth.
Manuel Hayn,
M. Hirschenberger,
L. Koepke,
R. Nchioua,
J. H. Straub,
S. Klute,
V. Hunszinger,
Fabian Zech,
Caterina Prelli Bozzo,
Wasim Aftab,
...
M. H. Christensen,
Carina Conzelmann,
Janis A. Müller,
Smitha Srinivasachar Badarinarayan,
C. Stürzel,
I. Forné,
S. Stenger,
K. Conzelmann,
J. Münch,
F. Schmidt,
D. Sauter,
A. Imhof,
F. Kirchhoff,
K. Sparrer
|
7 |
2021 |
7
🐜
|
|
🐜
|
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
30 auth.
Lukas Wettstein,
Tatjana Weil,
Carina Conzelmann,
Janis A. Müller,
R. Gross,
M. Hirschenberger,
Alina Seidel,
S. Klute,
Fabian Zech,
Caterina Prelli Bozzo,
Nico Preising,
G. Fois,
R. Lochbaum,
P. Knaff,
V. Mailänder,
...
L. Ständker,
D. Thal,
C. Schumann,
S. Stenger,
A. Kleger,
G. Lochnit,
B. Mayer,
Yasser B. Ruiz-Blanco,
M. Hoffmann,
K. Sparrer,
S. Pöhlmann,
E. Sánchez-García,
F. Kirchhoff,
M. Frick,
J. Münch
|
6 |
2021 |
6
🐜
|
|
🐜
|
ARF1 prevents aberrant type I interferon induction by regulating STING activation and recycling
30 auth.
M. Hirschenberger,
A. Lepelley,
U. Rupp,
S. Klute,
V. Hunszinger,
L. Koepke,
V. Merold,
B. Didry-Barca,
F. Wondany,
T. Bergner,
Tatiana Moreau,
M. Rodero,
Reinhild Rösler,
Sebastian Wiese,
Stefano Volpi,
...
M. Gattorno,
R. Papa,
S. Lynch,
M. Haug,
Gunnar Houge,
K. Wigby,
Jessica Sprague,
J. Lenberg,
Clarissa Read,
Paul Walther,
Jens Michaelis,
F. Kirchhoff,
C. C. de Oliveira Mann,
Y. Crow,
K. Sparrer
|
4 |
2023 |
4
🐜
|
|
🐜
|
Alpha-1 antitrypsin inhibits SARS-CoV-2 infection
25 auth.
Lukas Wettstein,
Carina Conzelmann,
Janis A. Müller,
Tatjana Weil,
R. Gross,
M. Hirschenberger,
Alina Seidel,
S. Klute,
Fabian Zech,
C. P. Bozzo,
Nico Preising,
G. Fois,
R. Lochbaum,
P. Knaff,
V. Mailänder,
...
L. Ständker,
D. Thal,
C. Schumann,
S. Stenger,
A. Kleger,
G. Lochnit,
K. Sparrer,
F. Kirchhoff,
M. Frick,
J. Münch
|
4 |
2020 |
4
🐜
|
|
🐜
|
Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1
17 auth.
R. Nchioua,
Annika Schundner,
S. Klute,
L. Koepke,
M. Hirschenberger,
Sabrina Noettger,
G. Fois,
Fabian Zech,
A. Graf,
S. Krebs,
...
P. Braubach,
H. Blum,
S. Stenger,
Dorota Kmieć,
M. Frick,
F. Kirchhoff,
K. Sparrer
|
3 |
2023 |
3
🐜
|
|
🐜
|
The Delta variant of SARS-CoV-2 maintains high sensitivity to interferons in human lung cells
13 auth.
R. Nchioua,
Annika Schundner,
S. Klute,
Sabrina Noettger,
Fabian Zech,
L. Koepke,
A. Graf,
S. Krebs,
H. Blum,
Dorota Kmieć,
...
M. Frick,
F. Kirchhoff,
K. Sparrer
|
3 |
2021 |
3
🐜
|
|
🐜
|
Imperfect innate immune antagonism renders SARS-CoV-2 vulnerable towards IFN-γ and -λ
23 auth.
Manuel Hayn,
M. Hirschenberger,
L. Koepke,
J. H. Straub,
R. Nchioua,
M. H. Christensen,
S. Klute,
C. P. Bozzo,
Wasim Aftab,
Fabian Zech,
...
Carina Conzelmann,
Janis A. Müller,
S. Badarinarayan,
C. Stürzel,
I. Forné,
S. Stenger,
K. Conzelmann,
J. Münch,
D. Sauter,
F. Schmidt,
A. Imhof,
F. Kirchhoff,
K. Sparrer
|
2 |
2020 |
2
🐜
|
|
🦁
|
Friends and Foes: The Ambivalent Role of Autophagy in HIV-1 Infection
S. Klute,
K. Sparrer
|
2 |
2024 |
2
🦁
|
